TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Cellcyte Genetics Corporation (OTC: CCYG) Investor Securities Class Action Lawsuit 01/14/2008

  • If you purchased shares of CellCyte Genetics Corporation (OTC: CCYG), you might have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

Case Dismissed
Company
Cellcyte Genetics Corporation
Security
OTC: CCYG

Case Name
Cellcyte Genetics Corporation Shareholder Class Action Lawsuit 01/14/2008
Type of Lawsuit
Shareholder Class Action
Court of Filing
U.S. District Court for the Western District of Washington

Class Period Begin
Class Period End
Deadline To File for Lead
You must register or login to receive notifications.

Click here to subscribe to Cellcyte Genetics Corporation.
Summary

March 23, 2010 - The court granted the defendants' motions to dismiss without prejudice.
March 5, 2009 - The defendants filed motions to dismiss.

February 3, 2009 - The lead plaintiffs filed a second amended complaint.

January 20, 2009 - The court granted lead plaintiffs' motion to amend.

December 19, 2008 - The lead plaintiffs filed a motion to amend.

November 10, 2008 - The defendants filed numerous motions to dismiss.

September 3, 2008 - A substitute lead plaintiff was appointed.

August 13, 2008 - A motion to substitute lead plaintiff due to death was filed.

July 10, 2008 - The lead plaintiffs filed an amended consolidated complaint.

April 28, 2008 - The lead plaintiffs and lead counsel were appointed and all cases were consolidated.

March 14, 2008 - Lead plaintiff motions were filed.

February 1, 2008 - Additional investors filed complaints.

January 14, 2008 - An investor in shares of CellCyte Genetics Corporation (OTC: CCYG) filed a lawsuit in the U.S. District Court for the Western District of Washington against CellCyte Genetics Corporation over alleged violations of Federal Securities Laws in connection with certain allegedly false and misleading statements made between April 6, 2007 and January 9, 2008.

According to the complaint CellCyte Genetics Corporation executives and business partners misled investors by publishing false information between April 6, 2007 and January 9, 2008, about the history and experience of CellCyte Genetics Corporation’s chief executive officer.

The lawsuit alleges that CellCyte Genetics Corporation (OTC: CCYG) shares were traded at artificially inflated prices due to CellCyte Genetics Corporation’s activities.

CellCyte Genetics Corporation’s chief executive officer’s education and professional credentials were called into question after published news reports called out alleged discrepancies relating to his finance degree from the University of Washington, a CPA designation, ties to the Washington Society of Certified Public Accountants and a strong track record within the pharmaceutical industry. Soon after these reports CellCyte Genetics Corporation (OTC: CCYG) stock plummeted 55 percent.